Local Consolidative Therapy versus Maintenance Therapy/Observation for Patients with Oligometastatic Non-Small Cell Lung Cancer without Progression after Front-Line Systemic Therapy: Results of a Multi-Institutional Phase II Randomized Study

BACKGROUND: Retrospective evidence indicates that disease progression after first-line chemotherapy for metastatic non-small cell lung cancer (NSCLC) occurs most often at sites of disease known to exist at baseline. However, the potential benefit of aggressive local consolidative therapy (LCT) on pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Daniel R., Blumenschein, George R., Lee, J. Jack, Hernandez, Mike, Ye, Rong, Camidge, D. Ross, Doebele, Robert C., Skoulidis, Ferdinandos, Gaspar, Laurie E., Gibbons, Don L., Karam, Jose A., Kavanagh, Brian D., Tang, Chad, Komaki, Ritsuko, Louie, Alexander V., Palma, David A., Tsao, Anne S., Sepesi, Boris, William, William N., Zhang, Jianjun, Shi, Qiuling, Wang, Xin Shelley, Swisher, Stephen G., Heymach, John V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143183/
https://www.ncbi.nlm.nih.gov/pubmed/27789196
http://dx.doi.org/10.1016/S1470-2045(16)30532-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143183/
https://www.ncbi.nlm.nih.gov/pubmed/27789196
http://dx.doi.org/10.1016/S1470-2045(16)30532-0

Ejemplares similares